{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:53:33Z","timestamp":1791161613833,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labour and Welfare, Japan"}],"content-domain":{"domain":["healthpolicyjrnl.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Health Policy"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.healthpol.2014.07.016","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T03:16:25Z","timestamp":1406862985000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Considering economic analyses in the revision of the preventive vaccination law: A new direction for health policy-making in Japan?"],"prefix":"10.1016","volume":"118","author":[{"given":"Manabu","family":"Akazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Yongue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunya","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.healthpol.2014.07.016_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7883\/yoken.JJID.2002.101","article-title":"Development of vaccination policy in Japan: current issues and policy directions","volume":"55","author":"Nakatani","year":"2002","journal-title":"Japanese Journal of Infectious Diseases"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0010","unstructured":"Ministry of Health, Labour and Welfare Amend Preventive Vaccination Law March 2013, \u3008www.mhlw.go.jp\/topics\/bukyoku\/soumu\/houritu\/183.html\u3009; 2013 [in Japanese]."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0015","unstructured":"Ministry of Health, Labour and Welfare Organization of the Ministry of Health, Labour and Welfare, \u3008www.mhlw.go.jp\/english\/org\/detail\/index.html\u3009; 2012."},{"issue":"32","key":"10.1016\/j.healthpol.2014.07.016_bib0020","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1016\/j.vaccine.2012.04.026","article-title":"Current issues with the immunization program in Japan: can we fill the vaccine gap?","volume":"30","author":"Saitoh","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.healthpol.2014.07.016_bib0025","first-page":"263","article-title":"The status of hepatitis vaccines: type a and type B","volume":"44","author":"Iino","year":"2001","journal-title":"Japan Medical Association Journal"},{"issue":"2","key":"10.1016\/j.healthpol.2014.07.016_bib0030","first-page":"75","article-title":"Revision of preventive vaccination law and future trends","volume":"45","author":"Kamiya","year":"2002","journal-title":"Japan Medical Association Journal"},{"issue":"3","key":"10.1016\/j.healthpol.2014.07.016_bib0035","first-page":"191","article-title":"Combined measles and rubella (MR) vaccine introduced in Japan","volume":"51","author":"Okabe","year":"2008","journal-title":"Japan Medical Association Journal"},{"issue":"3","key":"10.1016\/j.healthpol.2014.07.016_bib0040","first-page":"186","article-title":"Perspective on current vaccination policy in Japan","volume":"51","author":"Tsukahara","year":"2012","journal-title":"Japan Medical Association Journal"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.healthpol.2012.05.012","article-title":"The vaccine gap between Japan and the UK","volume":"107","author":"Shimazawa","year":"2012","journal-title":"Health Policy"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0963180110000058","article-title":"Japanese childhood vaccination policy","volume":"19","author":"Doshi","year":"2010","journal-title":"Cambridge Quarterly of Healthcare Ethics"},{"issue":"2","key":"10.1016\/j.healthpol.2014.07.016_bib0055","first-page":"106","article-title":"Current incident status of vaccine-preventable bacterial and viral infectious diseases in Japan","volume":"53","author":"Kamiya","year":"2010","journal-title":"Japan Medical Association Journal"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0060","unstructured":"National Institute of Infectious Disease. Routine and voluntary vaccinations in Japan (effective since November 1, 2012), \u3008www.nih.go.jp\/niid\/images\/vaccine\/schedule\/2012\/ImmEN121101.pdf\u3009; 2012."},{"issue":"2","key":"10.1016\/j.healthpol.2014.07.016_bib0065","first-page":"111","article-title":"The current state of immunization administration in Japan","volume":"53","author":"Enami","year":"2010","journal-title":"Japan Medical Association Journal"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0070","doi-asserted-by":"crossref","unstructured":"Asahi Shimbun, Japan trailing the West in vaccine programs (April 24, 2010), \u3008www.asahi.com\/english\/TKY201004230392.html\u3009; 2010.","DOI":"10.1016\/S1365-6937(10)70074-5"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0075","unstructured":"The Japan Times Vaccination policy booster, Editorial (March 6, 2011), \u3008www.japantimes.co.jp\/text\/ed20110306a1.html\u3009; 2011."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0080","unstructured":"Yomiuri Shimbun, Govt to expand routine vaccinations\/Standards for children will newly cover cervical cancer, meningitis as soon as fiscal 2013 (May 18, 2012), \u3008www.yomiuri.co.jp\/dy\/national\/T120517005394.htm\u3009; 2012."},{"issue":"5","key":"10.1016\/j.healthpol.2014.07.016_bib0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1010539511418101","article-title":"Factors associated with preferences for health system goals in Japan: a pilot study of the World Health Survey","volume":"23","author":"Wada","year":"2011","journal-title":"Asia Pacific Journal Public Health"},{"issue":"11","key":"10.1016\/j.healthpol.2014.07.016_bib0090","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1742-1241.2011.02766.x","article-title":"Japan's immunisation policy in routine, pandemic and post-tsunami situations","volume":"65","author":"Murashige","year":"2011","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0095","doi-asserted-by":"crossref","unstructured":"OECD, Health at a glance 2013: OECD indicators, OECD Publishing 2013; \u3008http:\/\/dx.doi.org\/10.1787\/health_glance-2013-en\u3009.","DOI":"10.1787\/health_glance-2013-en"},{"issue":"9797","key":"10.1016\/j.healthpol.2014.07.016_bib0100","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(11)60987-2","article-title":"Cost containment and quality of care in Japan: is there a trade-off","volume":"378","author":"Hashimoto","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0105","unstructured":"Infectious Diseases Sectional Committee. Conference minutes and documents, \u3008www.mhlw.go.jp\/stf\/shingi\/2r98520000008f2q.html#shingi12\u3009; 2012 [in Japanese]."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0110","unstructured":"Infectious Diseases Sectional Committee. Final subcommittee report (March 11, 2011), \u3008www.mhlw.go.jp\/stf\/shingi\/2r98520000014w74-att\/2r98520000014w9e.pdf\u3009; 2011 [in Japanese]."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3999\/jscpt.41.245","article-title":"Economic analysis of vaccine programs","volume":"41","author":"Akazawa","year":"2010","journal-title":"Japanese Journal of Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.healthpol.2014.07.016_bib0120","first-page":"233","article-title":"Economic evaluations of vaccines","volume":"49","author":"Ikeda","year":"2013","journal-title":"Farumashia"},{"issue":"9","key":"10.1016\/j.healthpol.2014.07.016_bib0125","first-page":"1214","article-title":"Analysis of the disease burden caused by Hib meningitis and cost-effectiveness analysis of Hib vaccine","volume":"110","author":"Kamiya","year":"2006","journal-title":"Journal of the Japan Pediatric Society"},{"issue":"4","key":"10.1016\/j.healthpol.2014.07.016_bib0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1542\/peds.110.4.653","article-title":"Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis","volume":"110","author":"Zhou","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0135","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hec.1481","article-title":"International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness","volume":"19","author":"Shiroiwa","year":"2010","journal-title":"Health Economics"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0140","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1046\/j.1440-1746.2000.02098.x","article-title":"Perinatal transmission of hepatitis B virus and its prevention","volume":"15","author":"Shiraki","year":"2000","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1016\/j.healthpol.2014.07.016_bib0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-3148.2009.00930.x","article-title":"Effect of selective vaccination on a decrease in the rate of hepatitis B virus-positive Japanese first-time blood donors","volume":"19","author":"Yoshikawa","year":"2009","journal-title":"Transfusion Medicine"},{"issue":"6","key":"10.1016\/j.healthpol.2014.07.016_bib0150","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1473-3099(07)70136-6","article-title":"Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?","volume":"7","author":"Zuckerman","year":"2007","journal-title":"Lancet Infectious Diseases"},{"issue":"3","key":"10.1016\/j.healthpol.2014.07.016_bib0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/eurpub\/ckm123","article-title":"Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation","volume":"18","author":"Tilson","year":"2008","journal-title":"European Journal of Public Health"},{"issue":"11","key":"10.1016\/j.healthpol.2014.07.016_bib0160","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00520-012-1576-7","article-title":"Hepatitis B virus management to prevent reactivation after chemotherapy: a review","volume":"20","author":"Hwang","year":"2012","journal-title":"Support Care in Cancer"},{"issue":"1","key":"10.1016\/j.healthpol.2014.07.016_bib0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1440-1746.2012.07280.x","article-title":"Hepatitis B virus reactivation associated with anti-neoplastic therapy","volume":"28","author":"Yeo","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.healthpol.2014.07.016_bib0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12185-009-0359-5","article-title":"Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma","volume":"90","author":"Kusumoto","year":"2009","journal-title":"International Journal of Hematology"},{"issue":"1","key":"10.1016\/j.healthpol.2014.07.016_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00535-010-0331-4","article-title":"Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy","volume":"46","author":"Kusumoto","year":"2011","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0180","unstructured":"New Komeito New Komeito's latest immunization initiative: the Hib vaccine (November 25, 2010), \u3008www.komei.or.jp\/en\/policy\/stands\/20101130.html\u3009; 2010."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0185","unstructured":"Japan Child Meningtis Organization, \u3008zuimakuen.net\/index\u3009; 2012 [in Japanese]."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0190","unstructured":"Japan Pediatric Society. Emergency appeal (November 17, 2010), \u3008www.jpeds.or.jp\/uploads\/files\/saisin_101210.pdf\u3009; 2010 [in Japanese]."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0195","unstructured":"Reuters. Japan halts Pfizer and Sanofi vaccines after four die (March 7, 2011), \u3008www.reuters.com\/article\/2011\/03\/07\/us-japan-vaccine-idUSTRE7260LY20110307\u3009; 2011."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0200","unstructured":"Prime Minister's Office of Japan. Great east Japan earthquake (March 11, 2011), \u3008www.kantei.go.jp\/foreign\/incident\/index.html\u3009; 2011."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0205","unstructured":"Yomiuri Shimbun, New vaccinations place burden on local govts\/Govt wants to add 7 immunizations to routine program; municipalities protest over increased costs (May 27, 2012), \u3008www.yomiuri.co.jp\/dy\/national\/T120526002416.htm\u3009; 2012."},{"issue":"42","key":"10.1016\/j.healthpol.2014.07.016_bib0210","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.vaccine.2008.07.085","article-title":"The role of economic information in decision-making by the Advisory Committee on Immunization Practices","volume":"26","author":"Dempsey","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.healthpol.2014.07.016_bib0215","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.vaccine.2010.02.025","article-title":"Informing decision makers: experience and process of 15 National Immunization Technical Advisory Groups","volume":"28","author":"Gessner","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.healthpol.2014.07.016_bib0220","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1542\/peds.2007-1115H","article-title":"Working group on leading economic issues for new vaccine for adolescents. Projected cost-effectiveness of new vaccines for adolescents in the United States","volume":"121","author":"Ortega-Sanchez","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0225","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.vaccine.2009.01.030","article-title":"Leadership in immunization: the relevance to Japan of the U.S.A. experience of the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP)","volume":"27","author":"Kamiya","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.healthpol.2014.07.016_bib0230","unstructured":"Joint Committee on Vaccination and Immunization (JCVI). JCVI statement on Human papillomavirus vaccines to protect against cervical cancer (June 18, 2008), \u3008webarchive.nationalarchives.gov.uk\/\u3009; 2008."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0235","unstructured":"PHARMA JAPAN. Health Sciences Council to Upgrade Committee on Immunization to Department on Preventive Vaccination and Vaccines (February 7, 2013), \u3008pj.jiho.jp\/servlet\/pjh\/regulatory\/detail\/1226571942652.html\u3009; 2013."},{"key":"10.1016\/j.healthpol.2014.07.016_bib0240","unstructured":"Central Social Insurance Medical Council. Special committee on cost-effectiveness evaluation (May 23, 2012), \u3008www.mhlw.go.jp\/stf\/shingi\/2r9852000002a7mj.html\u3009; 2012 [in Japanese]."},{"issue":"6","key":"10.1016\/j.healthpol.2014.07.016_bib0245","first-page":"625","article-title":"Guideline for economic evaluation of healthcare technologies in Japan","volume":"62","author":"Fukuda","year":"2013","journal-title":"Journal of the National Institute of Public Health"}],"container-title":["Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168851014001973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168851014001973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:25:12Z","timestamp":1746321912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168851014001973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0168851014001973"],"URL":"https:\/\/doi.org\/10.1016\/j.healthpol.2014.07.016","relation":{},"ISSN":["0168-8510"],"issn-type":[{"value":"0168-8510","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considering economic analyses in the revision of the preventive vaccination law: A new direction for health policy-making in Japan?","name":"articletitle","label":"Article Title"},{"value":"Health Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healthpol.2014.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}